Innovative Research to Improve Native Hawaiian and Pacific Islander (NHPI) Health Outcomes (R34 - Clinical Trial Optional)
Agency
National Institutes of Health
Posted
Aug 25, 2026
Due Date
Feb 16, 2027
Description
<p>The National Institute on Minority Health and Health Disparities (NIMHD), intends to publish a Notice of Funding Opportunity (NOFO) for planning grants to support preparatory, feasibility, and pilot activities that advance intervention development or solutions-oriented etiologic studies aimed at improving health and reducing health disparities outcomes among Native Hawaiian and Pacific Islander (NHPI) populations. Projects must be co-developed with community partners. Areas of interest include, but are not limited to:</p><ul style="list-style-type:disc;"><li data-list-item-id="e12275e844d3404ce3141d4f5574991b0">Formative studies to identify novel or understudied contributors to poor health outcomes and/or chronic diseases such as cancer and diabetes</li><li data-list-item-id="e7a6a8cf850b4db7f1cc17f31299c0cef">Planning, adapting, and pilot-testing interventions for prevention, early detection, or control of maternal morbidity, infant health problems, or high-prevalence diseases </li><li data-list-item-id="ec31c3208e01642bca67feb6fff40fad6">Feasibility and acceptability testing of strategies to reduce behavioral risk factors (e.g., physical inactivity, poor nutrition, or smoking) and promote sustained behavior change and measurable health outcomes</li></ul><p> </p>
AI Summary
Estimated Funding: 3,000,000 | Agency: National Institutes of Health
Details
- Notice ID
- 363713
- Solicitation Number
- RFA-MD-27-004
- Classification Code
- D
Want to track opportunities like this?
Sign up for Kontratar to get AI-powered opportunity matching, ranking, and alerts.
Get Started FreeRelated opportunities
- Leveraging NAMs to understand disease triggers, discover early biomarkers and develop new classes of therapeutic strategies for Type 1 Diabetes (U01 Clinical Trial Not Allowed)
National Institutes of Health
- Systems Biology of Infection and Inflammation in Chronic Diseases (U19 Clinical Trial Not Allowed)
National Institutes of Health
- Research on System Support and Tools for Provider Training and Quality Monitoring for Suicide Preventive Care (RP1- Clinical Trial Optional)
National Institutes of Health
- Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)
National Institutes of Health
- The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) - Clinical Research Centers (U01 Clinical Trial Not Allowed)
National Institutes of Health
- The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) Scientific Data Research Center (U24 Clinical Trial Not Allowed)
National Institutes of Health
- Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
National Institutes of Health
- George M. O’Brien Urology Cooperative Research Centers Program (U54 Clinical Trial Optional)
National Institutes of Health